Viemed Healthcare (VMD) Free Cash Flow Growth (1y) (2019 - 2026)
Viemed Healthcare (VMD) Free Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -31.71% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 133.09% |
| 10 | Viemed Healthcare | 465.59 Mn | 455.82 Mn | 42.83 Mn | 276.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 276.26% |
| Dec 31, 2025 | -41.86% |
| Sep 30, 2025 | 455.28% |
| Jun 30, 2025 | -178.23% |
| Mar 31, 2025 | 38.47% |
| Dec 31, 2024 | 32.88% |
| Sep 30, 2024 | -473.49% |
| Jun 30, 2024 | 1.09% |
| Mar 31, 2024 | -121.55% |
| Dec 31, 2023 | 324.06% |
| Sep 30, 2023 | -109.70% |
| Jun 30, 2023 | 264.53% |
| Mar 31, 2023 | -17.47% |
| Dec 31, 2022 | -18.13% |
| Sep 30, 2022 | 324.93% |
| Jun 30, 2022 | -199.38% |
| Mar 31, 2022 | 148.89% |
| Dec 31, 2021 | -35.25% |
| Sep 30, 2021 | -8.79% |
| Jun 30, 2021 | -69.91% |